Suppr超能文献

凋亡抵抗性内皮祖细胞移植改善糖尿病肾病的肾功能。

Transplantation of Apoptosis-Resistant Endothelial Progenitor Cells Improves Renal Function in Diabetic Kidney Disease.

机构信息

Department of Medicine School of Medicine and Health Sciences The George Washington University Washington DC.

Department of Medicine Veterans Affairs Medical Center Washington DC.

出版信息

J Am Heart Assoc. 2021 Apr 6;10(7):e019365. doi: 10.1161/JAHA.120.019365. Epub 2021 Mar 24.

Abstract

Background Diabetic kidney disease is associated with glomerulosclerosis and poor renal perfusion. Increased capillary formation and improved perfusion may help to halt or reverse the injury. Transplanting apoptosis-resistant p53-silenced endothelial progenitor cells (p53sh-EPCs) may help improve vascularization and renal perfusion and could be more beneficial than another stem cell such as the mouse mesenchymal stromal cell (mMSC). Methods and Results Hyperglycemia and proteinuria were confirmed at 8 to 10 weeks in streptozotocin-induced type1 diabetic C57Bl/6 mice, followed by transplantation of 0.3 million p53sh-EPCs, Null-EPCs (control), or mMSC under each kidney capsule. Urine was collected weekly for creatinine and protein levels. Blood pressure was measured by direct arterial cannulation and renal perfusion was measured by renal ultrasound. The kidneys were harvested for histology and mRNA expression. Reduction of protein/creatinine (AUC) was observed in p53sh-EPC-transplanted mice more than null-EPC (1.8-fold, =0.03) or null-mMSC (1.6-fold, =0.04, n=4) transplanted mice. Markers for angiogenesis, such as endothelial nitric oxide synthase (1.7-fold, =0.06), were upregulated post p53sh-EPC transplantation compared with null EPC. However, vascular endothelial growth factor-A expression was reduced (7-fold, =0.0004) in mMSC-transplanted mice, compared with p53sh-EPC-transplanted mice. Isolectin-B4 staining of kidney section showed improvement of glomerular sclerosis when p53sh-EPC was transplanted, compared with null-EPC or mMSC. In addition, mean and peak renal blood velocity (1.3-fold, =0.01, 1.4-fold, =0.001, respectively) were increased in p53sh-EPC-transplanted mice, relative to null-EPC transplanted mice. Conclusions Apoptosis-resistant p53sh EPC transplantation could be beneficial in the treatment of diabetic kidney disease by decreasing proteinuria, and improving renal perfusion and glomerular architecture.

摘要

背景

糖尿病肾病与肾小球硬化和肾脏灌注不良有关。增加毛细血管形成和改善灌注可能有助于阻止或逆转损伤。移植凋亡抗性 p53 沉默的内皮祖细胞(p53sh-EPC)可能有助于改善血管生成和肾脏灌注,并且可能比另一种干细胞如鼠间充质基质细胞(mMSC)更有益。

方法和结果

在链脲佐菌素诱导的 1 型糖尿病 C57Bl/6 小鼠中,8 至 10 周时确认高血糖和蛋白尿,然后在每个肾脏囊下移植 30 万个 p53sh-EPC、Null-EPC(对照)或 mMSC。每周收集尿液以测量肌酐和蛋白质水平。通过直接动脉插管测量血压,通过肾脏超声测量肾脏灌注。收获肾脏进行组织学和 mRNA 表达分析。与 Null-EPC(1.8 倍,=0.03)或 Null-mMSC(1.6 倍,=0.04,n=4)移植小鼠相比,p53sh-EPC 移植小鼠的蛋白/肌酐(AUC)减少。移植 p53sh-EPC 后,血管生成标志物如内皮型一氧化氮合酶(1.7 倍,=0.06)上调。然而,与 p53sh-EPC 移植小鼠相比,mMSC 移植小鼠的血管内皮生长因子-A 表达减少(7 倍,=0.0004)。肾脏切片的异硫氰酸荧光素-B4 染色显示,与 Null-EPC 或 mMSC 相比,移植 p53sh-EPC 可改善肾小球硬化。此外,与 Null-EPC 移植小鼠相比,p53sh-EPC 移植小鼠的平均和峰值肾血流速度分别增加(1.3 倍,=0.01,1.4 倍,=0.001)。

结论

凋亡抗性 p53sh-EPC 移植可通过减少蛋白尿、改善肾脏灌注和肾小球结构,有益于糖尿病肾病的治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3565/8174326/601d59691191/JAH3-10-e019365-g003.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验